Henry Ji
Vorstandsvorsitzender bei SORRENTO THERAPEUTICS, INC.
Vermögen: 693 713 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Henry Ji
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 58 | |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA.
19
| Subsidiary | Pharmaceuticals: Major | 19 |
Public Company | Pharmaceuticals: Other | 14 | |
Quikbyte Software, Inc.
Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL.
12
| Extinct | Financial Conglomerates | 12 |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ.
12
| Subsidiary | Miscellaneous Commercial Services | 12 |
Extinct | Biotechnology | 11 | |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Elsie Biotechnologies Inc. is a private company located in California that is focused on utilizing RNA therapeutics to treat diseases that were previously considered undruggable. The American company's platform enables the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. The company was founded in 2021 by Philip E. Dawson and Phil Baran, and the CEO is Kyle Jenne.
5
| Private Company | Biotechnology | 5 |
Subsidiary | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Henry Ji
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CELULARITY INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member President Director/Board Member Chief Administrative Officer Chief Operating Officer | |
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Compliance Officer Sales & Marketing General Counsel | |
University of California San Diego | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
SEQUENOM, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Sales & Marketing Corporate Officer/Principal | |
Tufts University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | Medical Specialties | Founder Founder Founder | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Arizona State University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
OPKO HEALTH, INC. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Brown University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
CARDIFF ONCOLOGY, INC. | Medical Specialties | Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Arizona | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
ERBA DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
IMMUNITYBIO, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Weill Cornell Medical College | College/University | Doctorate Degree Corporate Officer/Principal | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
Rutgers State University of New Jersey | College/University | Masters Business Admin Doctorate Degree | |
Transworld Investment Corp.
Transworld Investment Corp. Investment Banks/BrokersFinance Transworld Investment Corp. provides investment banking services. The private company is based in Miami, FL. Glenn L. Halpryn has been the CEO of the company since 1984. | Investment Banks/Brokers | Chief Executive Officer Director of Finance/CFO | |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Medical Distributors | Sales & Marketing Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Doctorate Degree | |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
CHROMADEX CORPORATION | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director/Board Member | |
CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
NEXGEL, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 50 |
Frankreich | 2 |
Sektoral
Health Technology | 26 |
Consumer Services | 13 |
Finance | 7 |
Health Services | 3 |
Commercial Services | 2 |
Operativ
Director/Board Member | 555 |
Corporate Officer/Principal | 261 |
Independent Dir/Board Member | 161 |
Chairman | 111 |
Chief Executive Officer | 97 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Tommy Thompson | 57 |
Robin Smith | 46 |
Kok Thay Lim | 43 |
John Sculley | 39 |
Jerome Zeldis | 38 |
Mohsin Meghji | 36 |
Jane Hsaio | 35 |
Mahendra Shah | 34 |
Andrew von Eschenbach | 32 |
Elizabeth Czerepak | 31 |
Brent Ahrens | 30 |
Edgar Lee | 26 |
Andrew Pecora | 25 |
Michael Blaszyk | 24 |
Cam Gallagher | 24 |